4-(Hydroxymethyl)-2-pyridinecarboxaldehyde is a reactant that has been used in the preparation of edotecarin analogues as potent topoisomerase I inhibitors with cytotoxic (CTX) activities against MKN-45 human stomach cancer or MX-1 human breast cancer.
